December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

40.29 +0.52 (+1.31%)
Delayed Quote Updated: 4:00 PM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
42 43 Next >
News headline image
Sanofi Earns Price Target Cut After Stopping Breast Cancer Drug Trial ↗
 
Via Benzinga
News headline image
Sanofi, Children's Place And Some Other Big Stocks Moving Lower On Wednesday ↗
  Embark Technology, Inc. (NASDAQ: EMBK) fell 25.1% to $12.40. Embark Technology reported the completion of reverse stock split. 
Via Benzinga
News headline image
Sanofi's Run Of Bad Luck Continues As Pharma Giant Tosses Out A Cancer Drug ↗
Shares extended deep losses following a Zantac-inspired downturn last week. 
Via Investor's Business Daily
News headline image
Benzinga Before The Bell: More Amazon Workers Join Union Over Pay and Work Conditions, UK Inflation Highest In 40 Years, Sole Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand And Other Top Financial Stories Wednesday, August 17 ↗
CNBC BlackRock To Pledge A$1B In Australian Battery Storage Assets – Report 
Via Benzinga
News headline image
Sanofi, Innovent Biologics Collaborate On Cancer Treatments In China ↗
 
Via Benzinga
News headline image
Sanofi Ekes Out Narrow Beat As Eczema Giant Scores Massive Gain ↗
The company reported more than 40% growth for Dupixent in the second quarter. 
Via Investor's Business Daily
News headline image
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus... 
Via Benzinga
News headline image
Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure ↗
 
Via Benzinga
News headline image
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket ↗
Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share. 
Via Benzinga
News headline image
Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus ↗
New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area. 
Via Benzinga
News headline image
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke ↗
Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 22 companies reached new 52-week lows. 
Via Benzinga
News headline image
GSK, PFE, SNY Stocks Fall on Zantac Litigation ↗
You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions. 
Via InvestorPlace
News headline image
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms ↗
These companies are at the center of lawsuits claiming Zantac causes cancer. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers that traders need to watch! 
Via InvestorPlace
News headline image
Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗
 
Via Benzinga
News headline image
WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday ↗
  OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  During Wednesday, 52 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Sanofi (NASDAQ:SNY) Shareholder Notice: Investigation Concerning Possible Violations of Securities Laws ↗
San Diego, CA -- (SBWIRE) -- 08/09/2022 -- Sanofi is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Monkeypox Plays Jockey For Position This Week
Via AB Newswire
News headline image
Looking Into Sanofi's Recent Short Interest ↗
Sanofi's (NASDAQ:SNY) short percent of float has fallen 25.0% since its last report. The company recently reported that it has 2.31 million shares sold short, which is 0.09% of... 
Via Benzinga
News headline image
How Siga Is Turning Its Biowarfare Soldier Onto This Outbreak ... And The Next ↗
Siga stock more than tripled, emerging from under the radar to take on the outbreak. 
Via Investor's Business Daily
News headline image
Regeneron's Prostate Cancer Combo Candidate Shows Encouraging Anti-Tumor Activity ↗
 
Via Benzinga
News headline image
A Bearish Sign Appears On Sanofi's Chart ↗
If history is any guide, there may be trouble ahead for shares of Sanofi (NASDAQ:SNY). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock. 
Via Benzinga
News headline image
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
3-D Portfolio: Discounts, Diversification, And Dividends ↗
When it comes to high-yield closed-end funds, I’m a big fan of the “three Ds” — discounts, diversification, and dividends. Today, we’ll look at a three-fund, bargain-priced “3-D” CEF portfolio you can... 
Via Talk Markets
News headline image
Week In Review: China Biopharma Tops $2.8 Billion In Week's Dealmaking ↗
CSPC Pharma out-licensed global rights for its antibody drug conjugate targeting Claudin18.2 to Elevation Oncology of New York City. CSPC will receive a $27 million upfront payment and up to $148... 
Via Talk Markets
News headline image
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.